Down-regulated of PCDH10 predicts poor prognosis in hepatocellular carcinoma patients

Protocadherin10 (PCDH10), a member of the nonclustered protocadherin family, functions as a tumor suppressor in many cancers. The aim of this study was to evaluate the expression level and prognostic value of PCDH10 in hepatocellular carcinoma (HCC) patients. Quantitative real-time polymerase chain...

Descripción completa

Detalles Bibliográficos
Autores principales: Bing, Yuntao, Tian, Maolin, Li, Gang, Jiang, Bin, Ma, Zhaolai, Li, Lei, Wang, Liang, Wang, Hangyan, Xiu, Dianrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392931/
https://www.ncbi.nlm.nih.gov/pubmed/30170418
http://dx.doi.org/10.1097/MD.0000000000012055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392931/
https://www.ncbi.nlm.nih.gov/pubmed/30170418
http://dx.doi.org/10.1097/MD.0000000000012055

Ejemplares similares